Literature DB >> 15555570

Identification and functional analysis of consensus androgen response elements in human prostate cancer cells.

Kuniko Horie-Inoue1, Hidemasa Bono, Yasushi Okazaki, Satoshi Inoue.   

Abstract

Androgen receptor (AR) recognizes and binds to 15-bp palindromic androgen response element (ARE) sequences with high affinity in vitro, which consist of two hexameric half-sites arranged as inverted repeats with a 3-bp spacer. Although a few near-consensus ARE sequences have been actually identified in the transcriptional regulatory regions of androgen-responsive genes, it has been unclear whether the exact consensus sequences function as bona fide AREs in vivo. A genome-wide in silico screening of palindromic AREs identified 563 exact consensus sequences in the human genome. The distribution of perfect palindromic AREs among the chromosomes is basically consistent with the length of chromosomes. Using human prostate cancer cell line LNCaP treated with a synthetic androgen R1881 as a model, in vivo AR binding abilities of 21 consensus AREs were analyzed by chromatin immunoprecipitation. Of 21 genomic fragments containing perfect AREs in chromosome X, 8 fragments recruited more ARs (>4-fold enrichment) even compared with the proximal ARE region of prostate-specific antigen. A couple of proximal genes or putative transcripts in the vicinity of the perfect AREs were found to be androgen-responsive analyzed by quantitative RT-PCR. Our results suggest that some of perfect palindromic AREs could function as in vivo AR binding sites in the human genome and regulate gene transcription.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15555570     DOI: 10.1016/j.bbrc.2004.10.174

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Resolving intralocus sexual conflict: genetic mechanisms and time frame.

Authors:  Andrew D Stewart; Alison Pischedda; William R Rice
Journal:  J Hered       Date:  2010 Mar-Apr       Impact factor: 2.645

2.  Saccharomyces cerevisiae BLYAS, a new bioluminescent bioreporter for detection of androgenic compounds.

Authors:  Melanie L Eldridge; John Sanseverino; Alice C Layton; James P Easter; T Wayne Schultz; Gary S Sayler
Journal:  Appl Environ Microbiol       Date:  2007-08-03       Impact factor: 4.792

3.  Adaptor Aly and co-adaptor Thoc5 function in the Tap-p15-mediated nuclear export of HSP70 mRNA.

Authors:  Jun Katahira; Hitomi Inoue; Ed Hurt; Yoshihiro Yoneda
Journal:  EMBO J       Date:  2009-01-22       Impact factor: 11.598

4.  Association of double-positive FOXA1 and FOXP1 immunoreactivities with favorable prognosis of tamoxifen-treated breast cancer patients.

Authors:  Nobuhiro Ijichi; Takashi Shigekawa; Kazuhiro Ikeda; Kuniko Horie-Inoue; Chikako Shimizu; Shigehira Saji; Kenjiro Aogi; Hitoshi Tsuda; Akihiko Osaki; Toshiaki Saeki; Satoshi Inoue
Journal:  Horm Cancer       Date:  2012-04-03       Impact factor: 3.869

5.  FOXP1, an estrogen-inducible transcription factor, modulates cell proliferation in breast cancer cells and 5-year recurrence-free survival of patients with tamoxifen-treated breast cancer.

Authors:  Takashi Shigekawa; Nobuhiro Ijichi; Kazuhiro Ikeda; Kuniko Horie-Inoue; Chikako Shimizu; Shigehira Saji; Kenjiro Aogi; Hitoshi Tsuda; Akihiko Osaki; Toshiaki Saeki; Satoshi Inoue
Journal:  Horm Cancer       Date:  2011-10       Impact factor: 3.869

6.  27-Hydroxycholesterol stimulates cell proliferation and resistance to docetaxel-induced apoptosis in prostate epithelial cells.

Authors:  Shaneabbas Raza; Megan Meyer; Jared Schommer; Kimberly D P Hammer; Bin Guo; Othman Ghribi
Journal:  Med Oncol       Date:  2016-01-05       Impact factor: 3.064

7.  Cisplatin enhances NK cells immunotherapy efficacy to suppress HCC progression via altering the androgen receptor (AR)-ULBP2 signals.

Authors:  Liang Shi; Hui Lin; Gonghui Li; Yin Sun; Jiliang Shen; Junjie Xu; Changyi Lin; Shuyuan Yeh; Xiujun Cai; Chawnshang Chang
Journal:  Cancer Lett       Date:  2016-01-19       Impact factor: 8.679

8.  The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis.

Authors:  Charles E Massie; Andy Lynch; Antonio Ramos-Montoya; Joan Boren; Rory Stark; Ladan Fazli; Anne Warren; Helen Scott; Basetti Madhu; Naomi Sharma; Helene Bon; Vinny Zecchini; Donna-Michelle Smith; Gina M Denicola; Nik Mathews; Michelle Osborne; James Hadfield; Stewart Macarthur; Boris Adryan; Scott K Lyons; Kevin M Brindle; John Griffiths; Martin E Gleave; Paul S Rennie; David E Neal; Ian G Mills
Journal:  EMBO J       Date:  2011-05-20       Impact factor: 11.598

9.  Genome-wide approaches for identification of nuclear receptor target genes.

Authors:  Luz E Tavera-Mendoza; Sylvie Mader; John H White
Journal:  Nucl Recept Signal       Date:  2006-07-07

10.  Topoisomerase 2 Alpha Cooperates with Androgen Receptor to Contribute to Prostate Cancer Progression.

Authors:  J L Schaefer-Klein; Stephen J Murphy; Sarah H Johnson; George Vasmatzis; Irina V Kovtun
Journal:  PLoS One       Date:  2015-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.